CD19 and neoplasm: Compared with the control no-treatment group, T, CAR-T, and hiPS-CAR-T cells showed inhibitory effects on CD19-positive Raji cells, and hiPS-CAR-T cells showed the strongest inhibitory effect on the migration and invasion of tumor Raji cells (Figures 4B, C), which was significantly higher than the control no CAR group.